Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings

William R. Miranda, Donald J. Hagler, Guy S. Reeder, Carole A. Warnes, Heidi M. Connolly, Alexander Egbe, Nathaniel W. Taggart

Research output: Contribution to journal › Review article

Abstract

Objective: To review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction. Background: ASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited. Methods: Retrospective review of 27 patients age ≥ 50 years undergoing temporary ASD balloon occlusion between 2000 and 2018 for suspected LV diastolic dysfunction or elevated LV end-diastolic pressure (LVEDP). Results: Median age was 72 years (IQR 66.7; 75.2). Atrial fibrillation was seen in 58% of patients, hypertension in 58%, and coronary artery disease in 26%; 52% were females. Median ASD size was 13 mm (10; 18) and Qp/Qs 1.8 (1.6; 2.2). Median LVEDP was 14 mmHg (12; 22); pulmonary artery wedge pressure (PAWP) 12 mmHg (9; 16.5) and left atrial pressure (LAP) 13.5 mmHg (8; 16.3). After a median of 5 min (3; 10) of balloon occlusion, patients with baseline LVEDP ≥15 mmHg had more significant increases in LVEDP (9 [6; 12] vs. 2 mmHg [0.5; 5]; p = 0.03) and LAP/PAWP (10.5 [8.3; 16.3] vs. 1.5 mmHg [−1.5; 3]; p = 0.0003) than those with baseline LVEDP <15 mmHg. None of those with a baseline LVEDP <15 mmHg had a LAP/PAWP >15 mmHg during balloon testing compared to 92% of patients with a baseline LVEDP ≥15 mmHg. Conclusion: LVEDP might be used to predict LAP post-ASD closure. Comorbidities typically associated with LV diastolic dysfunction are common in these patients and should be considered in their management.

Original languageEnglish (US)
JournalCatheterization and Cardiovascular Interventions
DOIs
StatePublished - Jan 1 2019

Fingerprint

Balloon Occlusion
Atrial Heart Septal Defects
Left Ventricular Dysfunction
Hemodynamics
Blood Pressure
Atrial Pressure
Pulmonary Wedge Pressure
Atrial Fibrillation
Comorbidity
Coronary Artery Disease
Hypertension

Keywords

  • adult congenital heart disease
  • atrial septal defect
  • hemodynamics
  • left ventricular diastolic dysfunction

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction : Hemodynamic and clinical findings. / Miranda, William R.; Hagler, Donald J.; Reeder, Guy S.; Warnes, Carole A.; Connolly, Heidi M.; Egbe, Alexander; Taggart, Nathaniel W.

In: Catheterization and Cardiovascular Interventions, 01.01.2019.

Research output: Contribution to journal › Review article

Miranda, WR, Hagler, DJ, Reeder, GS, Warnes, CA, Connolly, HM, Egbe, A & Taggart, NW 2019, 'Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings', Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.28150
Miranda WR, Hagler DJ, Reeder GS, Warnes CA, Connolly HM, Egbe A et al. Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings. Catheterization and Cardiovascular Interventions. 2019 Jan 1. https://doi.org/10.1002/ccd.28150
Miranda, William R. ; Hagler, Donald J. ; Reeder, Guy S. ; Warnes, Carole A. ; Connolly, Heidi M. ; Egbe, Alexander ; Taggart, Nathaniel W. / Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction : Hemodynamic and clinical findings. In: Catheterization and Cardiovascular Interventions. 2019.
@article{b3d686d47c514b0cb50128aa4cb2fcf0,
title = "Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings",
abstract = "Objective: To review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction. Background: ASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited. Methods: Retrospective review of 27 patients age ≥ 50 years undergoing temporary ASD balloon occlusion between 2000 and 2018 for suspected LV diastolic dysfunction or elevated LV end-diastolic pressure (LVEDP). Results: Median age was 72 years (IQR 66.7; 75.2). Atrial fibrillation was seen in 58{\%} of patients, hypertension in 58{\%}, and coronary artery disease in 26{\%}; 52{\%} were females. Median ASD size was 13 mm (10; 18) and Qp/Qs 1.8 (1.6; 2.2). Median LVEDP was 14 mmHg (12; 22); pulmonary artery wedge pressure (PAWP) 12 mmHg (9; 16.5) and left atrial pressure (LAP) 13.5 mmHg (8; 16.3). After a median of 5 min (3; 10) of balloon occlusion, patients with baseline LVEDP ≥15 mmHg had more significant increases in LVEDP (9 [6; 12] vs. 2 mmHg [0.5; 5]; p = 0.03) and LAP/PAWP (10.5 [8.3; 16.3] vs. 1.5 mmHg [−1.5; 3]; p = 0.0003) than those with baseline LVEDP <15 mmHg. None of those with a baseline LVEDP <15 mmHg had a LAP/PAWP >15 mmHg during balloon testing compared to 92{\%} of patients with a baseline LVEDP ≥15 mmHg. Conclusion: LVEDP might be used to predict LAP post-ASD closure. Comorbidities typically associated with LV diastolic dysfunction are common in these patients and should be considered in their management.",
keywords = "adult congenital heart disease, atrial septal defect, hemodynamics, left ventricular diastolic dysfunction",
author = "Miranda, {William R.} and Hagler, {Donald J.} and Reeder, {Guy S.} and Warnes, {Carole A.} and Connolly, {Heidi M.} and Alexander Egbe and Taggart, {Nathaniel W.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/ccd.28150",
language = "English (US)",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction

T2 - Hemodynamic and clinical findings

AU - Miranda, William R.

AU - Hagler, Donald J.

AU - Reeder, Guy S.

AU - Warnes, Carole A.

AU - Connolly, Heidi M.

AU - Egbe, Alexander

AU - Taggart, Nathaniel W.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: To review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction. Background: ASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited. Methods: Retrospective review of 27 patients age ≥ 50 years undergoing temporary ASD balloon occlusion between 2000 and 2018 for suspected LV diastolic dysfunction or elevated LV end-diastolic pressure (LVEDP). Results: Median age was 72 years (IQR 66.7; 75.2). Atrial fibrillation was seen in 58% of patients, hypertension in 58%, and coronary artery disease in 26%; 52% were females. Median ASD size was 13 mm (10; 18) and Qp/Qs 1.8 (1.6; 2.2). Median LVEDP was 14 mmHg (12; 22); pulmonary artery wedge pressure (PAWP) 12 mmHg (9; 16.5) and left atrial pressure (LAP) 13.5 mmHg (8; 16.3). After a median of 5 min (3; 10) of balloon occlusion, patients with baseline LVEDP ≥15 mmHg had more significant increases in LVEDP (9 [6; 12] vs. 2 mmHg [0.5; 5]; p = 0.03) and LAP/PAWP (10.5 [8.3; 16.3] vs. 1.5 mmHg [−1.5; 3]; p = 0.0003) than those with baseline LVEDP <15 mmHg. None of those with a baseline LVEDP <15 mmHg had a LAP/PAWP >15 mmHg during balloon testing compared to 92% of patients with a baseline LVEDP ≥15 mmHg. Conclusion: LVEDP might be used to predict LAP post-ASD closure. Comorbidities typically associated with LV diastolic dysfunction are common in these patients and should be considered in their management.

AB - Objective: To review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction. Background: ASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited. Methods: Retrospective review of 27 patients age ≥ 50 years undergoing temporary ASD balloon occlusion between 2000 and 2018 for suspected LV diastolic dysfunction or elevated LV end-diastolic pressure (LVEDP). Results: Median age was 72 years (IQR 66.7; 75.2). Atrial fibrillation was seen in 58% of patients, hypertension in 58%, and coronary artery disease in 26%; 52% were females. Median ASD size was 13 mm (10; 18) and Qp/Qs 1.8 (1.6; 2.2). Median LVEDP was 14 mmHg (12; 22); pulmonary artery wedge pressure (PAWP) 12 mmHg (9; 16.5) and left atrial pressure (LAP) 13.5 mmHg (8; 16.3). After a median of 5 min (3; 10) of balloon occlusion, patients with baseline LVEDP ≥15 mmHg had more significant increases in LVEDP (9 [6; 12] vs. 2 mmHg [0.5; 5]; p = 0.03) and LAP/PAWP (10.5 [8.3; 16.3] vs. 1.5 mmHg [−1.5; 3]; p = 0.0003) than those with baseline LVEDP <15 mmHg. None of those with a baseline LVEDP <15 mmHg had a LAP/PAWP >15 mmHg during balloon testing compared to 92% of patients with a baseline LVEDP ≥15 mmHg. Conclusion: LVEDP might be used to predict LAP post-ASD closure. Comorbidities typically associated with LV diastolic dysfunction are common in these patients and should be considered in their management.

KW - adult congenital heart disease

KW - atrial septal defect

KW - hemodynamics

KW - left ventricular diastolic dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85061427631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061427631&partnerID=8YFLogxK

U2 - 10.1002/ccd.28150

DO - 10.1002/ccd.28150

M3 - Review article

C2 - 30747481

AN - SCOPUS:85061427631

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -

Access to Document